Active Constituents of Psilocybin Mushroom Edibles

Richard B. van Breemen, Daniel Simchuk, Bjorn Fritzsche, Daniel Huson, Scott Kuzdzal, Jonathan Ferguson

Study at a glance

Characteristics	Case series Case report Peer reviewed
Population	Unregulated psilocybin mushroom edibles
Topics	Psilocybin
Citations	1
Key findings	Unregulated psilocybin mushroom edibles contain multiple active alkaloids with inconsistent concentrations and labeling.

This case series evaluates the active constituents of unregulated psilocybin mushroom edibles.

Other case reports and case series on psilocybin, most cited first.

Study	Year	Design	Participants
Psilocybin Mushroom (Psilocybe semilanceata) Intoxication with Myocardial Infarction 18-year-old man	1998	Case study	n = 1
Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF) Person with leg amputation and phantom-limb pain	2018	Case study	n = 1
Hallucinogen persisting perception disorder after psilocybin consumption: a case study 18-year-old man with HPPD after mixed psilocybin and cannabis intoxication	2005	Case study	n = 1
Microdosing psilocybin for chronic pain: a case series Individuals with chronic neuropathic pain	2022	Case series	n = 3
Psilocybin and Obsessive Compulsive Disorder Individual with Obsessive Compulsive Disorder	2014	Case study	n = 1